Free Trial

Kevin Havelock Acquires 37,000 Shares of Fevertree Drinks (LON:FEVR) Stock

Fevertree Drinks logo with Consumer Defensive background

Key Points

  • Kevin Havelock, an insider at Fevertree Drinks PLC, purchased 37,000 shares at an average cost of GBX 846 per share, totaling £313,020 on September 11th.
  • The stock's current price is GBX 892, with a past year low of GBX 608.50 and high of GBX 1,020, amid a market capitalization of £1.06 billion.
  • Analysts have mixed opinions, with Deutsche Bank lifting the price target to GBX 840 and Jefferies maintaining a "hold" rating with a target of GBX 900, indicating a cautious outlook on the stock.
  • MarketBeat previews the top five stocks to own by October 1st.

Fevertree Drinks PLC (LON:FEVR - Get Free Report) insider Kevin Havelock purchased 37,000 shares of the company's stock in a transaction that occurred on Thursday, September 11th. The shares were acquired at an average price of GBX 846 per share, for a total transaction of £313,020.

Fevertree Drinks Stock Performance

LON:FEVR traded up GBX 33 during trading hours on Wednesday, reaching GBX 917. The stock had a trading volume of 6,955,633 shares, compared to its average volume of 619,235. The company has a debt-to-equity ratio of 1.50, a quick ratio of 3.21 and a current ratio of 4.11. The stock has a 50 day simple moving average of GBX 891.98 and a 200 day simple moving average of GBX 846.83. Fevertree Drinks PLC has a 12-month low of GBX 608.50 and a 12-month high of GBX 1,020. The stock has a market cap of £1.09 billion, a P/E ratio of 4,398.08, a price-to-earnings-growth ratio of -4.51 and a beta of 1.07.

Fevertree Drinks (LON:FEVR - Get Free Report) last released its earnings results on Thursday, September 11th. The company reported GBX 6.85 earnings per share (EPS) for the quarter. Fevertree Drinks had a return on equity of 9.30% and a net margin of 6.05%. On average, research analysts forecast that Fevertree Drinks PLC will post 38.3184173 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. JPMorgan Chase & Co. lifted their price target on Fevertree Drinks from GBX 770 to GBX 850 and gave the company a "neutral" rating in a research report on Friday, September 12th. Jefferies Financial Group reiterated a "hold" rating and issued a GBX 900 price target on shares of Fevertree Drinks in a research report on Friday, September 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Fevertree Drinks from GBX 800 to GBX 840 and gave the company a "buy" rating in a research report on Thursday, September 11th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, Fevertree Drinks presently has an average rating of "Hold" and a consensus target price of GBX 863.33.

Get Our Latest Research Report on Fevertree Drinks

About Fevertree Drinks

(Get Free Report)

Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.

Featured Articles

Should You Invest $1,000 in Fevertree Drinks Right Now?

Before you consider Fevertree Drinks, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fevertree Drinks wasn't on the list.

While Fevertree Drinks currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.